| Date Filed | Type | Description |
| 06/09/2023 |
4
| Babler Martin (Director) has filed a Form 4 on Neoleukin Therapeutics, Inc.|
Txns:
| Granted 25,000 options to buy
@ $0.79, valued at
$19.8k
|
|
| 06/22/2022 |
4
| Babler Martin (Director) has filed a Form 4 on Prelude Therapeutics Inc|
Txns:
| Granted 31,293 options to buy
@ $4.74, valued at
$148.3k
|
|
| 05/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/20/2021 |
4
| Babler Martin (Director) has filed a Form 4 on Prelude Therapeutics Inc|
Txns:
| Granted 36,400 options to buy
@ $31.37, valued at
$1.1M
|
|
| 07/20/2021 |
3
| Babler Martin (Director) has filed a Form 3 on Prelude Therapeutics Inc |
| 05/13/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/06/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 09/28/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/10/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/10/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 06/25/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/05/2020 |
4
| Babler Martin (President, CEO) has filed a Form 4 on Principia Biopharma Inc.|
Txns:
| Gifted 1,159 shares
@ $0
Gifted 1,159 shares
@ $0
Sold 2,085 shares
@ $62.4476, valued at
$130.2k
Sold 7,183 shares
@ $63.2398, valued at
$454.3k
Sold 5,432 shares
@ $64.098, valued at
$348.2k
Sold 300 shares
@ $64.8267, valued at
$19.4k
Granted 200,000 options to buy
@ $67.31, valued at
$13.5M
|
|
| 12/19/2019 |
4
| Babler Martin (President, CEO) has filed a Form 4 on Principia Biopharma Inc.|
Txns:
| Sold 5,840 shares
@ $51.7983, valued at
$302.5k
Sold 11,485 shares
@ $52.8571, valued at
$607.1k
Sold 6,661 shares
@ $53.9429, valued at
$359.3k
Sold 1,014 shares
@ $54.355, valued at
$55.1k
Sold 1,000 shares
@ $52.7747, valued at
$52.8k
Sold 2,205 shares
@ $53.6926, valued at
$118.4k
Sold 1,295 shares
@ $54.2799, valued at
$70.3k
|
|
| 03/08/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/20/2018 |
4
| Babler Martin (CEO) has filed a Form 4 on Principia Biopharma Inc.|
Txns:
| Converted 988 shares
@ $0
Converted 240 shares
@ $0
Converted 988 shares
@ $0
Converted 240 shares
@ $0
Converted 988 shares
@ $0
Converted 240 shares
@ $0
Converted 988 options to buy
@ $0
Converted 988 options to buy
@ $0
Converted 988 options to buy
@ $0
Converted 240 preferred shares
@ $0
Converted 240 preferred shares
@ $0 |
|
| 09/13/2018 |
3
| Babler Martin (CEO) has filed a Form 3 on Principia Biopharma Inc. |
| 12/21/2015 |
4
| Babler Martin (Director) has filed a Form 4 on ZS Pharma, Inc.|
Txns:
| Disposed/sold 1,000 shares
@ $90, valued at
$90k
Disposed/sold 12,000 options to buy
@ $46.86, valued at
$562.3k
Disposed/sold 4,000 options to buy
@ $55.57, valued at
$222.3k
|
|
| 06/25/2015 |
4
| Babler Martin (Director) has filed a Form 4 on ZS Pharma, Inc.|
Txns:
| Granted 4,000 options to buy
@ $55.57, valued at
$222.3k
Granted 1,000 restricted stock units
@ $0 |
|
| 06/13/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/18/2012 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/19/2011 |
4
| Babler Martin (Director) has filed a Form 4 on INFINITY PHARMACEUTICALS, INC.|
Txns:
| Granted 6,000 options to buy
@ $6.8, valued at
$40.8k
Granted 2,000 options to buy
@ $6.8, valued at
$13.6k
|
|
| 05/27/2010 |
4
| Babler Martin (Director) has filed a Form 4 on INFINITY PHARMACEUTICALS, INC.|
Txns:
| Granted 5,625 options to buy
@ $6.74, valued at
$37.9k
Granted 1,875 options to buy
@ $6.74, valued at
$12.6k
|
|
| 06/19/2009 |
4
| Babler Martin (Director) has filed a Form 4 on INFINITY PHARMACEUTICALS, INC. |